MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2

Human Pathology

Volumn 46, Issue 7, 2015, Pages 971-980

  Lin, Lvbiao ^a   Zheng, Yungui ^a   Tu, Yanyang ^b   Wang, Zhen ^b   Liu, Hui ^b   Lu, Xiaowen ^a   Xu, Liepeng ^a   Yuan, Jun ^a  

^a SHANTOU UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Astrocytoma; Clinicopathological feature; Enhancer of zeste homolog 2; MicroRNA 144; Prognosis; Tumorigenesis

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 144; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; EZH2 PROTEIN, HUMAN; MIRN144 MICRORNA, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2;

ADULT; ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; CANCER PROGNOSIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PREDICTION; SURVIVAL RATE; TUMOR GENE; UPREGULATION; WORLD HEALTH ORGANIZATION; CANCER GRADING; CASE CONTROL STUDY; CELL MOTION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SIGNAL TRANSDUCTION; TIME; TREATMENT OUTCOME; TUMOR CELL LINE; TUMOR INVASION;

ADULT; ASTROCYTOMA; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; POLYCOMB REPRESSIVE COMPLEX 2; PROPORTIONAL HAZARDS MODELS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TREATMENT OUTCOME;

EID: 84931008742     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.01.023     Document Type: Article

References (28)

1. E. Dunbar, and A.T. Yachnis Astrocytoma diagnosis: immunohistochemistry and beyond Adv Anat Pathol 17 2010 187 201
2. D.N. Louis, H. Ohgaki, and O.D. Wiestler The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2007 97 109
3. X. Zhang, H. Yang, B. Gong, C. Jiang, and L. Yang Combined gene expression and protein interaction analysis of dynamic modularity in astrocytoma prognosis J Neurooncol 107 2012 281 288
4. R. Margueron, and D. Reinberg The polycomb complex PRC2 and its mark in life Nature 469 2011 343 349
5. G.J. van Leenders, D. Dukers, and D. Hessels Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features Eur Urol 52 2007 455 463
6. R.J. Bryant, N.A. Cross, C.L. Eaton, F.C. Hamdy, and V.T. Cunliffe EZH2 promotes proliferation and invasiveness of prostate cancer cells Prostate 67 2007 547 556
7. C.J. Chang, and M.C. Hung The role of EZH2 in tumour progression Br J Cancer 106 2012 243 247
8. B. Shi, J. Liang, and X. Yang Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells Mol Cell Biol 27 2007 5105 5119
9. Z.Y. Rao, M.Y. Cai, and G.F. Yang EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients Carcinogenesis 31 2010 1576 1583
10. Huqun, R. Ishikawa, and J. Zhang Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer Cancer 118 2012 1599 1606
11. M.L. Suvà, N. Riggi, and M. Janiszewska EZH2 is essential for glioblastoma cancer stem cell maintenance Cancer Res 69 2009 9211 9218
12. F. Orzan, S. Pellegatta, and P.L. Poliani Enhancer of zeste 2 (EZH2) is up-regulated in malignant astrocytomas and in astrocytoma stem-like cells Neuropathol Appl Neurobiol 37 2011 381 394
13. R. Zhang, R. Wang, and H. Chang Downregulation of Ezh2 expression by RNA interference induces cell cycle arrest in the G0/G1 phase and apoptosis in U87 human astrocytoma cells Oncol Rep 28 2012 2278 2284
14. M. Ott, U.M. Litzenburger, and F. Sahm Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase PLoS One 7 2012 e47663
15. Z. Wu, Q. Wang, and L. Wang Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in astrocytoma patients J Neurol Sci 335 2013 191 196
16. H. Dweep, C. Sticht, P. Pandey, and N. Gretz miRWalk - database: prediction of possible miRNA binding sites by "walking" the genes of three genomes J Biomed Inform 44 2011 839 847
17. S. Qiu, D. Huang, and D. Yin Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme Biochim Biophys Acta 2013 1832 1697 1707
18. M. Smits, J. Nilsson, and S.E. Mir miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis Oncotarget 1 2010 710 720
19. Q.C. Song, Z.B. Shi, and Y.T. Zhang Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients Oncol Rep 31 2014 1263 1270
20. P. Guo, Q. Nie, J. Lan, J. Ge, Y. Qiu, and Q. Mao C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells Biochem Biophys Res Commun 441 2013 186 190
21. N. Wu, X. Zhao, and M. Liu Role of microRNA-26b in astrocytoma development and its mediated regulation on EphA2 PLoS One 6 2011 e16264
22. C.M. Koh, T. Iwata, Q. Zheng, C. Bethel, S. Yegnasubramanian, and A.M. De Marzo Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms Oncotarget 2 2011 669 683
23. Y. Liang, Q. Lin, F. Luo, W. Wu, T. Yang, and S. Wan Requirement of miR-144 in CsA induced proliferation and invasion of human trophoblast cells by targeting titin J Cell Biochem 115 2014 690 696
24. S. Akiyoshi, T. Fukagawa, and H. Ueo Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases Br J Cancer 107 2012 1345 1353
25. W. Zha, L. Cao, Y. Shen, and M. Huang Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer PLoS One 8 2013 e74175
26. S.M. Sureban, R. May, and F.G. Mondalek Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism J Nanobiotechnol 9 2011 40
27. H.M. Namløs, L.A. Meza-Zepeda, and T. Barøy Modulation of the osteosarcoma expression phenotype by microRNAs PLoS One 7 2012 e48086
28. L.Y. Zhang, V.H.F. Lee, and A.M. Wong MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN Carcinogenesis 34 2013 454 463